Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is VISMODEGIB, with a corresponding US DMF Number 41222.
Remarkably, this DMF maintains an Active status since its submission on January 31, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 26, 2025, and payment made on January 28, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II